Xenon Pharmaceuticals, Inc. (XENE)
56.89
+0.20
(+0.35%)
USD |
NASDAQ |
Apr 02, 16:00
56.89
0.00 (0.00%)
After-Hours: 16:26
Xenon Pharmaceuticals Research and Development Expense (TTM) : 298.40M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 32.50M |
| Oncolytics Biotech, Inc. | 9.547M |
| Edesa Biotech, Inc. | 3.774M |
| Lexaria Bioscience Corp. | 6.957M |
| ProMIS Neurosciences, Inc. | 33.38M |